NVO

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

By Josh Enomoto, InvestorPlace Contributor
The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last…

The Top 3 Pharma Stocks to Buy in March 2024

By Shane Neagle, InvestorPlace Contributor
Investors explore the top three biotechnology stocks to buy in 2024, which are leading the anti-obesity market surge.

NVO Stock Alert: Novo Nordisk Pops on New Weight-Loss Drug

By William White, InvestorPlace Writer
Novo Nordisk stock is gaining on Thursday as NVO investors react to positive news from its new weight loss drug clinical trial.

Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making

By Terel Miles, InvestorPlace Contributor
These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.

Why Is Vivani Medical (VANI) Stock Up 300% Today?

By Josh Enomoto, InvestorPlace Contributor
With Vivani Medical introducing pre-clinical efficacy data for its weight-loss solution, VANI stock soared on the broader implications.

What Would George Soros Do? 7 Stocks the Billionaire’s Fund Bought & Sold in Q4

By Muslim Farooque, InvestorPlace Contributor
Dive into the insightful analysis on George Soros stocks in Q4 highlighting the foresight of an investing titan

Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now

By Alex Sirois, InvestorPlace Contributor
The seven companies discussed here have every chance of becoming the next trillion dollar stocks for investors.

3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024

By Jeremy Flint, InvestorPlace Contributor
Predicting top sectors isn't easy; we usually identify them only in hindsight, but these three stock market segments are rapidly rising.

Wealth Generators: 3 Growth Stocks You’ll Regret Not Buying in 2024

By Terel Miles, InvestorPlace Contributor
Novo Nordisk (NVO), Caterpillar (CAT), and First Solar (FSLR) are the 3 best growth stocks you'll regret now buying in 2024!

Meet the Next Trillion-Dollar Companies: Our Top 7 Picks

By Jeremy Flint, InvestorPlace Contributor
These future trillion-dollar stocks are on their way to mythic valuation, supported by strong underlying fundamentals and prospects.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor
Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks

By Paul R. La Monica, InvestorPlace Contributor
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?

By Rich Duprey, InvestorPlace Contributor
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

By William White, InvestorPlace Writer
Catalent stock is rising higher on Monday after the company announced a $16.5 billion cash acquisition deal for CTLT shares.

The Road to a Trillion: 3 Stocks Next in Line for the Mega Milestone

By Rich Duprey, InvestorPlace Contributor
Becoming a trillion-dollar milestone stock is more than just having a title. Rather, it indicates market dominance in the industry.

3 Phenomenal Stock-Split Stocks You Should Be Buying Now

By Rich Duprey, InvestorPlace Contributor
Because the market sees stock splits as a sign of future growth these stock-split stocks could be tomorrow's winners.

Global Giants: 3 Multinational Corporations to Outperform in 2024

By Charles Munyi, InvestorPlace Contributor
Participate in the growth of the global economy and consumption through these leading global stocks for 2024.

Why Is Omega Therapeutics (OMGA) Stock Up 111% Today?

By William White, InvestorPlace Writer
Omega Therapeutics stock is rising higher on Thursday as investors in OMGA react to a search collaboration agreement with Novo Nordisk.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Load More